Approved Products

(CE Mark, not for sale in United States)

 

The central laboratory-based tests currently used for diagnosing many different diseases cannot always deliver results to patients and health care providers in a timely or cost-effective manner.  BioMedomics has created and continues to develop new approaches to match the capabilities of POC testing with the needs of the emerging personal, physician and retail health care markets.  

Sickle SCAN®
Detects sickle cell disease and trait in 5 minutes

 

 

BioMedomics has developed a rapid, qualitative POC test for Sickle Cell Disease.  Currently SCD can only be tested with complex and expensive central lab equipment. This resulted in limited screening programs for newborn babies in Africa, India and other affected under-resourced countries that do not have the necessary infrastructure.  The lack of early detection has led to 50%-90% mortality rates for newborns with Sickle Cell Disease in these areas despite the availability of inexpensive lifesaving treatments.  There is an acute medical need for a simple, inexpensive SCD test for the 36 million annual births in these low resourced areas. 

Products in Development

 

BioMedomics' patented Time-Resolved lateral flow immunoassy technology is an advanced point-of-care platform that has the potential to provide significantly more sensitivity than other existing platforms. Sensitivity levels in the single picogram/mL range will allow the company to duplicate the sensitivity and accuracy now found only in central lab equipment.

Hemo SCAN®
Measures total hemoglobin level in seconds
 
Hemo SCAN is a quantitative hemoglobin concentration test for professional use. This highly sensitive device requires only 7 µL of capillary or venous blood to yield accurate results within seconds. The Hemo SCAN system displays real time data and store up to 500 samples. This product is ideal to help identify and treat anemia patients easily and quickly.
Hemo SCAN® S
Accurate Hemoglobin S measurement in 15 minutes
 

 

90% of Sickle Cell patients receive at least one blood transfusion in their lifetime. These blood transfusions not only help to maintain proper hemoglobin levels, but also to prevent stroke, one of the most common complications of the disease. However, excessive transfusion also carries risks. The monitoring of HbS (Hemoglobin S) concentration is key when considering transfusion or transfusion therapy adjustment for a Sickle Cell patient. Currently, the only methods to measure HbS are lab tests which could take 2-3 days to yield results, during that time, the physician could only rely on symptoms alone to make a judgement. As a point-of-care diagnostic test, Hemo SCAN®-S produces accurate results in 15 minutes, allowing timely, reliable clinical decisions.
Fungi SCAN®   
Rapid and Simple Fungi Infection Detection

Fungal infections are caused by fungi that are common in the environment, and can take place in different areas of the body, including skin, nails, genitals and other internal organs. Current testing methods for fungal infections are complex, time consuming and requires professional technicians. BioMedomics has developed the Fungi SCAN Enhanced Fungal Fluorescent Stain that helps physcians to rapidly detect fungal infections by combining direct microscopy and biochemical testing. The staining reagent binds to the fungal cell wall, allowing any fungi present to emit fluorescence that can be easily viewed with a fluorescent microscope.

Fetomaternal Hemorrhage

Fetomaternal hemorrhage refers to the entry of fetal blood into the maternal circulation before or during delivery. The incidence of fetomaternal hemorrhage has been estimated to be approximately 3 per 1,000 births. It can have devastating consequences for the fetus such as neurologic injury, stillbirth, or neonatal death. Presentation is frequently without an evident precipitating factor. Recognition may become apparent only after injury has occurred, if at all. The current testing method is severely outdated, and has a turnaround time from hours to days. Delayed treatment could have fatal consequences. We developed a point-of-care quantitative test that provides accurate results in 15 minutes, ensuring that current and accurate results are available to the healthcare provider when they are most valuable for decision-making.

BioMedomics, Inc.

1100 Perimeter Park Drive

Suite 104

Morrisville, NC 27560

USA

www.biomedomics.com

Tel: 919.890.3070

Email: info@biomedomics.com